Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes


Zaire ebolavirus (ZEBOV), a highly pathogenic zoonotic virus, poses serious public health, ecological and potential bioterrorism threats. Currently no specific therapy or vaccine is available. Virus entry is an attractive target for therapeutic intervention. However, current knowledge of the ZEBOV entry mechanism is limited. While it is known that ZEBOV enters cells through endocytosis, which of the cellular endocytic mechanisms used remains unclear. Previous studies have produced differing outcomes, indicating potential involvement of multiple routes but many of these studies were performed using noninfectious surrogate systems such as pseudotyped retroviral particles, which may not accurately recapitulate the entry characteristics of the morphologically distinct wild type virus. Here we used replication-competent infectious ZEBOV as well as morphologically similar virus-like particles in specific infection and entry assays to demonstrate that in HEK293T and Vero cells internalization of ZEBOV is independent of clathrin, caveolae, and dynamin. Instead the uptake mechanism has features of macropinocytosis. The binding of virus to cells appears to directly stimulate fluid phase uptake as well as localized actin polymerization. Inhibition of key regulators of macropinocytosis including Pak1 and CtBP/BARS as well as treatment with the drug EIPA, which affects macropinosome formation, resulted in significant reduction in ZEBOV entry and infection. It is also shown that following internalization, the virus enters the endolysosomal pathway and is trafficked through early and late endosomes, but the exact site of membrane fusion and nucleocapsid penetration in the cytoplasm remains unclear. This study identifies the route for ZEBOV entry and identifies the key cellular factors required for the uptake of this filamentous virus. The findings greatly expand our understanding of the ZEBOV entry mechanism that can be applied to development of new therapeutics as well as provide potential insight into the trafficking and entry mechanism of other filoviruses.


Vyšlo v časopise: Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001110
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001110

Souhrn

Zaire ebolavirus (ZEBOV), a highly pathogenic zoonotic virus, poses serious public health, ecological and potential bioterrorism threats. Currently no specific therapy or vaccine is available. Virus entry is an attractive target for therapeutic intervention. However, current knowledge of the ZEBOV entry mechanism is limited. While it is known that ZEBOV enters cells through endocytosis, which of the cellular endocytic mechanisms used remains unclear. Previous studies have produced differing outcomes, indicating potential involvement of multiple routes but many of these studies were performed using noninfectious surrogate systems such as pseudotyped retroviral particles, which may not accurately recapitulate the entry characteristics of the morphologically distinct wild type virus. Here we used replication-competent infectious ZEBOV as well as morphologically similar virus-like particles in specific infection and entry assays to demonstrate that in HEK293T and Vero cells internalization of ZEBOV is independent of clathrin, caveolae, and dynamin. Instead the uptake mechanism has features of macropinocytosis. The binding of virus to cells appears to directly stimulate fluid phase uptake as well as localized actin polymerization. Inhibition of key regulators of macropinocytosis including Pak1 and CtBP/BARS as well as treatment with the drug EIPA, which affects macropinosome formation, resulted in significant reduction in ZEBOV entry and infection. It is also shown that following internalization, the virus enters the endolysosomal pathway and is trafficked through early and late endosomes, but the exact site of membrane fusion and nucleocapsid penetration in the cytoplasm remains unclear. This study identifies the route for ZEBOV entry and identifies the key cellular factors required for the uptake of this filamentous virus. The findings greatly expand our understanding of the ZEBOV entry mechanism that can be applied to development of new therapeutics as well as provide potential insight into the trafficking and entry mechanism of other filoviruses.


Zdroje

1. HoenenT

GrosethA

FalzaranoD

FeldmannH

2006 Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med 12 206 215

2. LeroyEM

RouquetP

FormentyP

SouquiereS

KilbourneA

2004 Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303 387 390

3. EllisDS

SimpsonIH

FrancisDP

KnoblochJ

BowenET

1978 Ultrastructure of Ebola virus particles in human liver. J Clin Pathol 31 201 208

4. FeldmannH

KlenkHD

SanchezA

1993 Molecular biology and evolution of filoviruses. Arch Virol Suppl 7 81 100

5. DolnikO

KolesnikovaL

BeckerS

2008 Filoviruses: Interactions with the host cell. Cell Mol Life Sci 65 756 776

6. ChandranK

SullivanNJ

FelborU

WhelanSP

CunninghamJM

2005 Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308 1643 1645

7. SchornbergK

MatsuyamaS

KabschK

DelosS

BoutonA

2006 Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80 4174 4178

8. DohertyGJ

McMahonHT

2009 Mechanisms of Endocytosis. Annu Rev Biochem

9. MercerJ

HeleniusA

2009 Virus entry by macropinocytosis. Nat Cell Biol 11 510 520

10. PelkmansL

HeleniusA

2003 Insider information: what viruses tell us about endocytosis. Curr Opin Cell Biol 15 414 422

11. KartenbeckJ

StukenbrokH

HeleniusA

1989 Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol 109 2721 2729

12. WeedSA

ParsonsJT

2001 Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 20 6418 6434

13. FalconeS

CocucciE

PodiniP

KirchhausenT

ClementiE

2006 Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J Cell Sci 119 4758 4769

14. KerrMC

TeasdaleRD

2009 Defining macropinocytosis. Traffic 10 364 371

15. HagaY

MiwaN

JahangeerS

OkadaT

NakamuraS

2009 CtBP1/BARS is an activator of phospholipase D1 necessary for agonist-induced macropinocytosis. Embo J 28 1197 1207

16. LiberaliP

KakkonenE

TuracchioG

ValenteC

SpaarA

2008 The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. Embo J 27 970 981

17. HarbisonCE

LyiSM

WeichertWS

ParrishCR

2009 Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking. J Virol 83 10504 10514

18. JohnsHL

BerrymanS

MonaghanP

BelshamGJ

JacksonT

2009 A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry. J Virol 83 6247 6256

19. KolokoltsovAA

DenigerD

FlemingEH

RobertsNJJr

KarpilowJM

2007 Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol 81 7786 7800

20. SanchezA

2007 Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis 196 Suppl 2 S251 258

21. BhattacharyyaS

WarfieldKL

RuthelG

BavariS

AmanMJ

2010 Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 401 18 28

22. EmpigCJ

GoldsmithMA

2002 Association of the caveola vesicular system with cellular entry by filoviruses. J Virol 76 5266 5270

23. QuinnK

BrindleyMA

WellerML

KaludovN

KondratowiczA

2009 Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol 83 10176 10186

24. IvanovAI

2008 Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol 440 15 33

25. SaeedMF

KolokoltsovAA

FreibergAN

HolbrookMR

DaveyRA

2008 Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog 4 e1000141

26. AcostaEG

CastillaV

DamonteEB

2009 Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell Microbiol 11 1533 1549

27. SunX

YauVK

BriggsBJ

WhittakerGR

2005 Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 338 53 60

28. BeerC

AndersenDS

RojekA

PedersenL

2005 Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J Virol 79 10776 10787

29. PangH

LePU

NabiIR

2004 Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus. J Cell Sci 117 1421 1430

30. MaciaE

EhrlichM

MassolR

BoucrotE

BrunnerC

2006 Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10 839 850

31. EbiharaH

TheriaultS

NeumannG

AlimontiJB

GeisbertJB

2007 In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. J Infect Dis 196 Suppl 2 S313 322

32. BavariS

BosioCM

WiegandE

RuthelG

WillAB

2002 Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195 593 602

33. WestMA

PrescottAR

EskelinenEL

RidleyAJ

WattsC

2000 Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr Biol 10 839 848

34. KalinS

AmstutzB

GastaldelliM

WolfrumN

BouckeK

Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J Virol

35. FretzM

JinJ

ConibereR

PenningNA

Al-TaeiS

2006 Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV-TAT peptide and octaarginine. J Control Release 116 247 254

36. MercerJ

HeleniusA

2008 Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320 531 535

37. RaghuH

Sharma-WaliaN

VeettilMV

SadagopanS

ChandranB

2009 Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J Virol 83 4895 4911

38. Mercer J, Schelhaas M, Helenius A. Virus entry by endocytosis. Annu Rev Biochem 79 803 833

39. SimmonsG

RennekampAJ

ChaiN

VandenbergheLH

RileyJL

2003 Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 77 13433 13438

40. GrimmerS

van DeursB

SandvigK

2002 Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J Cell Sci 115 2953 2962

41. Le ClaincheC

CarlierMF

2008 Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 88 489 513

42. HenleyJR

CaoH

McNivenMA

1999 Participation of dynamin in the biogenesis of cytoplasmic vesicles. Faseb J 13 Suppl 2 S243 247

43. RouxA

UyhaziK

FrostA

De CamilliP

2006 GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission. Nature 441 528 531

44. MettlenM

PucadyilT

RamachandranR

SchmidSL

2009 Dissecting dynamin's role in clathrin-mediated endocytosis. Biochem Soc Trans 37 1022 1026

45. NomuraR

2005 [Caveolar endocytosis and virus entry]. Uirusu 55 19 26

46. Romer W, Pontani LL, Sorre B, Rentero C, Berland L, et al. Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis. Cell 140 540 553

47. SieczkarskiSB

WhittakerGR

2005 Characterization of the host cell entry of filamentous influenza virus. Arch Virol 150 1783 1796

48. MeierO

BouckeK

HammerSV

KellerS

StidwillRP

2002 Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 158 1119 1131

49. CoyneCB

ShenL

TurnerJR

BergelsonJM

2007 Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2 181 192

50. ShimojimaM

TakadaA

EbiharaH

NeumannG

FujiokaK

2006 Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 80 10109 10116

51. TakadaA

WatanabeS

ItoH

OkazakiK

KidaH

2000 Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278 20 26

52. LiC

MacdonaldJI

HryciwT

MeakinSO

2009 Nerve Growth Factor Activation of the TrkA Receptor Induces Cell Death, by Macropinocytosis, in Medulloblastoma Daoy Cells. J Neurochem

53. BryantDM

KerrMC

HammondLA

JosephSR

MostovKE

2007 EGF induces macropinocytosis and SNX1-modulated recycling of E-cadherin. J Cell Sci 120 1818 1828

54. MeierO

GreberUF

2004 Adenovirus endocytosis. J Gene Med 6 Suppl 1 S152 163

55. HewlettLJ

PrescottAR

WattsC

1994 The coated pit and macropinocytic pathways serve distinct endosome populations. J Cell Biol 124 689 703

56. MeertensL

BertauxC

DragicT

2006 Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80 11571 11578

57. LakadamyaliM

RustMJ

ZhuangX

2006 Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124 997 1009

58. JonesAT

2007 Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cell Mol Med 11 670 684

59. SandgrenKJ

WilkinsonJ

Miranda-SaksenaM

McInerneyGM

Byth-WilsonK

A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Pathog 6 e1000866

60. SaeedMF

KolokoltsovAA

DaveyRA

2006 Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. J Virol Methods 135 143 150

61. CarpenterAE

JonesTR

LamprechtMR

ClarkeC

KangIH

2006 CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7 R100

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 9
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa